Topic-Contributed Paper Session
Regulatory Acceptability of Bayesian and other Novel Statistical Methods
Bradley CarlinChair
Biopharmaceutical Section
4 Presentations
10:35 AM - 10:55 AM
John Scott (FDA)
10:55 AM - 11:15 AM
Lauren Frazee (PharmaLex)
11:35 AM - 11:55 AM
Ruitao Lin (University of Texas, MD Anderson Cancer Center)
Discussant
Freda Cooner (FDA)